Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Summary of Non-Vested Options (Detail)

v3.22.1
Stockholders' Equity - Summary of Non-Vested Options (Detail)
 3 Months Ended
Feb. 28, 2022
$ / shares
shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Non-vested at November 30, 2021, Shares | shares 63,034
Vested, Shares | shares (4,602)
Forfeited, Shares | shares (4,416)
Non-vested at February 28, 2022, Shares | shares 54,016
Non-vested at November 30, 2021, Weighted Average Grant-Date Fair Value | $ / shares $ 4.99
Vested, Weighted Average Grant-Date Fair Value | $ / shares 6.27
Forfeited, Weighted Average Grant-Date Fair Value | $ / shares 7.98
Non-vested at February 28, 2022, Weighted Average Grant-Date Fair Value | $ / shares $ 4.63